LexDanaLexDanabeta
Inventor

SCOTT PRESTON SIMONOVICH

Inventor
US

Overview

5→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
C07BGeneral methods of organic chemistry11%
C07KPeptides11%
PatentTitleYear
12,590,062PD-1/PD-L1 inhibitors202612,338,233PD-1/Pd-L1 inhibitors202512,269,812PD-1/PD-L1 inhibitors202511,555,029PD-1/PD-L1 inhibitors202311,274,105Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to AMGEN INC (1)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to GILEAD SCIENCES INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC42023–2026
AMGEN INC12022
Locations
LocationPatentsSpan
US52022–2026